Executives On The Move
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: Changes At Cian Healthcare, Abeona Therapeutics And More
New leaders in regulatory affairs and manufacturing at Pharnext SA and promotions at Abeona Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Onxeo SA, Avalo Therapeutics and Spero Therapeutics, among others.
Executives On The Move: Changes At Pieris, Skye Bioscience And More
New leaders in regulatory affairs and R&D at Skye Bioscience and promotions at Pieris Pharmaceuticals are among recent executive changes in the industry. Meanwhile, new directors were appointed at Summit Therapeutics, Ovid Therapeutics and Spero Therapeutics, among others.
IGM Thinks Outside Oncology Box With Anti-Infective, Autoimmune Play
The company created two new divisions focused on the new disease areas, bringing in former executives from Bristol Myers Squibb and Sanofi Pasteur.
Executives On The Move: Roivant And Amplia Among Firms Hiring New CFOs
Richard Pulik joins Roivant from Novartis, Hamish George joins Amplia from Dimerix, and Khiron, Immunovant, Quiapeg Pharmaceuticals and Vascular Biogenics also get new CFOs.
Executives On The Move: New CEOs At ReWind And Esker Therapeutics
Hyloris picks up new chief financial officer, new chief medical officer joins Cyclo and more.
Executives On The Move: Enveric Biosciences Announces New Leadership Team
New CEOs at Mirati Therapeutics Nordic Nanovector, Rappta Therapeutics and more.
Executives On The Move: New Chief Medical Officers At Biophytis, Eloxx And La Jolla
New chief financial officers at Alector, CanSino, and more.
Executives On The Move: New CEOs At BerGenBio, Civetta, Jubilant And More
Novartis gets new People And Organization Officer, plus new CEOs at BerGenBio, Pillar Biosciences, Pascal Biosciences, Jubilant and Civetta Therapeutics.
Executives On The Move: New Chief Business Innovation Officer For Pfizer
Aamir Malik leaves McKinsey & Co to join Pfizer as chief business innovation officer and executive vice president.
End Of An Era As Galapagos CEO Van De Stolpe Retires
Some 22 years after founding what was one of the biggest success stories in Europe's biotech sector before a recent series of setbacks in the clinic struck, Onno van de Stolpe has decided to retire as Galapagos CEO and the search has already started for his successor.
Executives On The Move: New CMOs at Bone Therapeutics, Xenon Pharmaceuticals & Novan
Former Tmunity Therapeutics CFO Simona King joins Passage Bio as CFO. Rune Skeie, CFO of BerGenBio, holds the fort as interim CEO until Martin Olin joins in September.
J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.